Final answer:
GpIIb/IIIa inhibitors like abciximab, eptifibatide, and tirofiban are not listed in the provided medications. They work by preventing platelet aggregation to treat cardiovascular diseases.
Step-by-step explanation:
The medication that inhibits the GpIIb/IIIa receptor is not listed among the provided medications (Rivaroxaban, Dabigatran, Apixaban, Heparin, Warfarin, Celecoxib, statins, or acetaminophen). GpIIb/IIIa inhibitors are a class of antiplatelet medications used to prevent blood clots. Examples of GpIIb/IIIa inhibitors include abciximab, eptifibatide, and tirofiban. These medications work by preventing platelets from aggregating and forming clots, which is essential in the treatment of various cardiovascular diseases such as acute coronary syndrome (ACS) and during percutaneous coronary intervention (PCI).